Sleep Medicine
Conference Coverage
Novel agent counters sleepiness in narcolepsy patients
Key clinical point: The distinct mechanism of action of JZP-110 might provide another option for narcolepsy patients who do not improve on, or...
Conference Coverage
Sleep society: Screen for apnea at first Medicare visit
Conference Coverage
People with SAD have reduced retinal sensitivity to light year round
Key clinical point: Patients with SAD may comply with treatment more willingly once they know the fault is in their pupils.Major finding: The...
News
Suicide more likely after midnight
Key clinical point: Nighttime wakefulness is a risk factor for suicide. Major finding: Suicides rose after midnight, peaking at a mean 16% at 2 a....
News
FDA requiring lower starting dose for another sleep drug, eszopiclone
Conference Coverage
Orexin antagonist improved sleep in phase III studies
Key clinical point: Orexin antagonist suvorexant improved sleep based on both subjective and objective measures, with minimal side effects.
News
Nocturnal cortisol levels predicted neurocognitive impairment in sleep apnea
Major finding: Nighttime cortisol levels accounted for 9%-16% of variance in learning, memory, and working memory, and apnea severity did not...